Literature DB >> 31037085

Protein Interaction Mapping related to Becker Muscular Dystrophy.

Ali Azghar Peyvandi1, Farshad Okhovatian2, Majid Rezaei Tavirani3, Mona Zamanian Azodi4, Mostafa Rezaei Tavirani4.   

Abstract

OBJECTIVE: Becker Muscular Dystrophy (BMD) is a neuromuscular disorder which is incurable. In this research protein interaction network of most associated proteins with BMD to provide better clarification of disorder underlying mechanism was investigated. MATERIALS &
METHODS: The related genes to BMD were retrieved via string database and conducted by Cytoscape and the related algorithms. The network centrality analysis was performed based on degree, betweenness, closeness, and stress parameters. Gene ontology and clustering were performed via ClueGO analysis.
RESULTS: DMD as the super-hub as well as other central proteins including UTRN, TTN, DNM2, and RYR1 are important in BMD in terms of interactive features. The impairment of muscular contraction may be vital in BMD disease pathogenesis as it is the highlighted biological process term obtained by ClueGO analysis.
CONCLUSION: DMD targeting may be the main concern for dystrophy clinical approaches. However, the other suggested proteins should be evaluated. Targeting these key proteins are required for treatment goals following extensive validation studies.

Entities:  

Keywords:  Becker muscular dystrophy (BMD); Gene ontology; Hub proteins; Map analysis; Protein-protein interaction

Year:  2019        PMID: 31037085      PMCID: PMC6451862     

Source DB:  PubMed          Journal:  Iran J Child Neurol        ISSN: 1735-4668


Introduction

Becker Muscular Dystrophy is a less severe type of dystrophy than Duchenne muscular dystrophy (1). This type of neuromuscular disorder is mainly known with dysfunctional protein dystrophin (2). As there is no therapy available for BMD, molecular examination can be helpful in this regard (3). The potential molecules contributing to disease pathogenesis can be targeted for treatments (4, 5). Many investigations in this light have been conducted and provided further information about this disease and with possible usage in clinical goals (6). The analysis conducted up until today showed the contribution of many molecules for this disease that worth more evaluations (7, 8). However, due to the complex molecular nature of muscular dystrophy, more studies in terms of proteins as the functional level of cell is required (9). The way these proteins communicate can their linkage results in many different phenotypes are known as protein-protein interaction network (10). Any changes in this interaction unit may lead to phenotype alterations and sometimes the manifestation of a specific disease. This procedure is related to how the communication of these proteins can affect other proteins and the contributing pathways (11). Therefore, by analyzing these features the possible knowledge of molecular behavior of any kinds of diseases can be better understood (12). In addition, by examining proteins with prioritized topological features, potential nominates for biomarker discovery can be introduced. Moreover, more in-depth knowledge can be achieved through these studies by exploring the functional roles and biological processes related to these central proteins (13). On the other hand, expression changes in these types may result in vast dysregulation in the whole PPI network and accordingly, a disease phenotype may manifest (13). Etiology of Becker muscular dystrophy can be better explained by protein-protein interaction (PPI) network analysis and wide validation methods applications. Here, an introductory network value of this important muscular disease is suggested.

Materials & Methods

For the network construction, the used application was Cytoscape 3.4.0. (14). Through Cytoscape, STRING Database provided the essential information for interaction pattern by the use of different sources and combined confidence score (15). The setting for network construction was as follows: Number of nodes: 100 and combined confidence score cutoff= 0.5. However, only 93 one among the 100 genes were included in the constructed network. Following network construction, connectivity degree (D), betweenness, closeness, and stress as the key topological parameters were adopted to interfere the centrality properties of the constructed network. Nodes with high degree values are known as hub proteins. Hubs have many connections and any changes in them can result in extensive disruption of the whole interaction system. Tnode with high value of betweenness is called bottleneck node (16). For node evaluation, 10 top nodes based on the four mentioned centrality parameters have been selected. In this way, the central nodes of a network identify (17). Further analysis was conducted based on gene ontology examinations. ClueGO+CluePedia Cytoscape plug-ins explored the gene ontology (GO) annotations (18, 19). Controlled vocabulary of three biological annotations including cellular component, molecular function, and biological process terms are implemented by GO source (20). The statistical test for this analysis was Kappa score. High kappa score indicates the higher possibility that terms group together. The cut off for here was set 0.5. In addition, genes per term was considered 3 and the percentage was set to 4. The minimum and maximum level of ontology were set to 3 to 8 as the default option, respectively. The P-value was also set to ≤0.05 and Bonferroni step down as the correction method. Two-sided (enrichment/depletion) based on hypergeometric test was also selected as the default option.

Results

Protein network construction of Becker muscular dystrophy via String Database and Cytoscape followed by is shown in Figure 1.
Figure 1

The network view of Becker muscular dystrophy analyzed by Cytoscape. Statistical properties of the network are shown in the down of the figure. Network consists of 93 nodes including 29 isolated nodes, one paired nodes and 62 organized nodes in the main connected component

The network view of Becker muscular dystrophy analyzed by Cytoscape. Statistical properties of the network are shown in the down of the figure. Network consists of 93 nodes including 29 isolated nodes, one paired nodes and 62 organized nodes in the main connected component Centrality analysis of the network was by the use of Network Analyzer. This algorithm is well established in Cytoscape and can provide essential topological parameters’ properties. Here, degree, betweenness, closeness, and stress as the most central characteristic of a PPI network are considered for centrality evaluation (Table 1). If a protein was hub or bottleneck and was included in the selected nodes based on closeness and stress was introduced as crucial proteins (Table 2). Gene ontology examination can be handled by the application of ClueGO. Here, the biological process evaluation of the main network was assessed (Figure 2).
Table 1

The 10 top nodes based on degree (D), betweenness (B), closeness (C) and stress (S)

R Gene Name D Gene Name B Gene Name C Gene Name S
1DMD39DMD0.406106GPR171DMD4516
2UTRN25DNM20.187341GRM31DNM22232
3SGCG19STAU10.12623DMD0.663043UTRN1890
4CAV319RYR10.103262UTRN0.544643TRIM321670
5TTN19UTRN0.095463TTN0.530435STAU11462
6SGCA17TTN0.074896CAV30.488MYOD11318
7CAPN316MYOD10.074827DAG10.484127RYR11200
8DAG116VCL0.073312DNM20.480315MYOG966
9SNTA115ILF20.064481RYR10.480315VCL928
10FKRP15MB0.043576SNTA10.469231ILF2736
Table 2

The crucial nodes considering a hub or bottleneck gene included in the selected nodes based on closeness and stress

R Gene Name Description D B c s Disease score
1DMDdystrophin390.410.6645164
2UTRNutrophin250.100.5418902.66
3TTNtitin190.070.53-1
4DNM2dynamin 290.190.4822322.22
5RYR1ryanodine receptor 1 (skeletal)120.100.4812000.87
Figure 2

The pie chart shows significant contributed biological processes related to the main network of the Becker muscular dystrophy. The most highlighted group here is the green part. The network statistical properties are as follow: P<0.05, Kappa Score=0.5

The 10 top nodes based on degree (D), betweenness (B), closeness (C) and stress (S) The crucial nodes considering a hub or bottleneck gene included in the selected nodes based on closeness and stress The pie chart shows significant contributed biological processes related to the main network of the Becker muscular dystrophy. The most highlighted group here is the green part. The network statistical properties are as follow: P<0.05, Kappa Score=0.5

Discussion

Topological examination implements remarkable properties of interaction basis of molecular concept of any kinds of diseases (21). Proteins with such characteristics are essential for network integrity and strength (22). In this study, proteins with such properties are suggested for BMD. In Figure 1, the first component of the network is a medium network that the most essential properties are contributing in this part. Other components are isolated or small communities not considered. No interactions between these nodes and the main network may be due to either undiscovered interactions or insignificant contribution of these proteins for BMD. The range of contribution of the isolated nodes to the disease is between 0.5-1 and for the other nodes is between 0.5-4 (Table 2). DMD has the highest score which is 4. Nodes within main network are more associated with BMD than the other ones to the disease. DMD plays a role as the core of the network. Furthermore, DMD is the highest scored in terms of degree and betweenness values, which is a top-rated hub and bottleneck node (hub-bottleneck node). The association between this protein and BMD is strong as indicated as disease score. By considering the five crucial genes, in fact, 8.5% of the nodes were considered as key proteins. These nodes include DMD, UTRN, TTN, DNM2, and RYR1. These proteins were again searched against literature and finally, the result showed that they are highly pertinent to BMD. In addition to high values of centrality parameters, the disease score values of these central nodes are is the highest compared to other nodes. Utrophin the other key protein is well known as a relevant protein to the two Duchenne and becker muscle dystrophies (23-25). Tight correlation between dystrophin and utrophin expression in Duchenne and becker patient is proved and discussed (26). Titin, the third key protein in the introduced possible biomarker panel is a giant sarcomeric filamentous polypeptide molecule. It is a component of striated muscle. There are evidence that titin plays a fundamental role in maintaining sarcomeric structural integrity. Responsibility for the passive elasticity of muscle is the main biological role of titin (27-29). The role of dynamin-2 (DNM2) in pathology of autosomal dominant centronuclear myopathy is investigated and reported by several researchers. This myopathy is usually a mild and clinically heterogeneous muscle disorder. Muscle weakness is the known characteristic of the patients. The nuclei are centralized in the biopsy of the patients (30-32). Encoding isoform ryanodine receptor in the skeletal muscle by RYR1 gene is reported. This protein has a fundamental role in the excitation-contraction coupling process in the skeletal muscle. Control of calcium homeostasis by RyR1 is a significant role of this gene because intracellular calcium channel has a crucial role in muscle contraction (33, 34). Centrality analysis indicates that while DMD has key properties in the network, other associated proteins may be fundamental in the BMD. Apparently, DMD is well-documented in Becker muscular dystrophy as well (35-37). Muscular dystrophy may trigger from malfunction of this protein. Role and centrality of this protein to be assessed also in other muscular dystrophies. Gene ontology analysis can express different properties of a group of proteins. The proteins contributing in a same network of BMD are inspected for biological process analysis. The biological process examination of BMD related proteins with different scores show that the Muscular Contraction is the most important biological process for BMD pathogenesis. Other processes are also important in this disease. Therefore, dysregulation of the assigned BMD proteins may lead to disruption of biological processes and mainly the highlighted one namely, Muscular Contraction. Muscle cell development and cardiac muscle tissue development are introduced as the second and the third important biological processes. As it is depicted in Figure 2, about 10 processes that tightly are related to the control of muscle function are listed. In conclusion, DMD targeting may be the main concern for dystrophy clinical approaches. However, the presence of the other central proteins in the introduced panel also is confirmed by literature. Validity of this finding is assessed via more complementary investigation.
  33 in total

1.  Mechanical unfolding intermediates in titin modules.

Authors:  P E Marszalek; H Lu; H Li; M Carrion-Vazquez; A F Oberhauser; K Schulten; J M Fernandez
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

2.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM.

Authors:  Montserrat Samsó; Terence Wagenknecht; P D Allen
Journal:  Nat Struct Mol Biol       Date:  2005-05-22       Impact factor: 15.369

4.  Computing topological parameters of biological networks.

Authors:  Yassen Assenov; Fidel Ramírez; Sven-Eric Schelhorn; Thomas Lengauer; Mario Albrecht
Journal:  Bioinformatics       Date:  2007-11-15       Impact factor: 6.937

Review 5.  Mutations in RYR1 in malignant hyperthermia and central core disease.

Authors:  Rachel Robinson; Danielle Carpenter; Marie-Anne Shaw; Jane Halsall; Philip Hopkins
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

6.  Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.

Authors:  Rachel D Susman; Susana Quijano-Roy; Nan Yang; Richard Webster; Nigel F Clarke; Jim Dowling; Marina Kennerson; Garth Nicholson; Valerie Biancalana; Biljana Ilkovski; Kevin M Flanigan; Susan Arbuckle; Chandra Malladi; Phillip Robinson; Steven Vucic; Michèle Mayer; Norma B Romero; Jon Andoni Urtizberea; Federico García-Bragado; Pascale Guicheney; Marc Bitoun; Robert-Yves Carlier; Kathryn N North
Journal:  Neuromuscul Disord       Date:  2010-03-12       Impact factor: 4.296

Review 7.  Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?

Authors:  Pedro Miura; Bernard J Jasmin
Journal:  Trends Mol Med       Date:  2006-01-27       Impact factor: 11.951

8.  Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.

Authors:  Heinz Jungbluth; Tom Cullup; Suzanne Lillis; Haiyan Zhou; Stephen Abbs; Caroline Sewry; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2009-11-22       Impact factor: 4.296

9.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.

Authors:  A H Beggs; E P Hoffman; J R Snyder; K Arahata; L Specht; F Shapiro; C Angelini; H Sugita; L M Kunkel
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

10.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Hubert Hackl; Pornpimol Charoentong; Marie Tosolini; Amos Kirilovsky; Wolf-Herman Fridman; Franck Pagès; Zlatko Trajanoski; Jérôme Galon
Journal:  Bioinformatics       Date:  2009-02-23       Impact factor: 6.937

View more
  1 in total

1.  Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma.

Authors:  Zhiying Lin; Zhu Zhang; Haojie Zheng; Haiyan Xu; Yajuan Wang; Chao Chen; Junlu Liu; Guozhong Yi; Zhiyong Li; Xiaoyan Wang; Guanglong Huang
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.